P Cacoub. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultAntiviral Agents/administration & dosageAntiviral Agents/therapeutic useChildFranceHepatitis C/complicationsHepatitis C/drug therapyHepatitis C/pathologyHumansInterferon alpha-2Interferon-alpha/administration & dosageInterferon-alpha/therapeutic usePolyethylene Glycols/administration & dosagePolyethylene Glycols/therapeutic useRecombinant ProteinsRibavirin/administration & dosageRibavirin/therapeutic use
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2a
Year: 2002 PMID: 12481388 DOI: 10.1016/s0248-8663(02)00714-2
Source DB: PubMed Journal: Rev Med Interne ISSN: 0248-8663 Impact factor: 0.728